The Frequency and Clinical Relevance of Multidrug Resistance Protein Expression in Patients with Lymphoma

---

Atıf İçin Kopyala

GÜNDÜZ E., Dincer M., Yildiz G., BAL C., Gulbas Z.

TURKISH JOURNAL OF HEMATOLOGY, cilt.29, sa.2, ss.120-125, 2012 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 29 Sayı: 2
• Basım Tarihi: 2012
• Doi Numarası: 10.5505/tjh.2012.60362
• Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.120-125
• Anahtar Kelimeler: Multidrug resistance, non-Hodgkin's lymphoma, Hodgkin's lymphoma, Survival, P-GLYCOPROTEIN EXPRESSION, GLUTATHIONE-S-TRANSFERASE, POLYMERASE-CHAIN-REACTION, ACUTE MYELOID-LEUKEMIA, DRUG-RESISTANCE, IMMUNOHISTOCHEMICAL EXPRESSION, REFRACTORY LYMPHOMA, POOR RESPONSE, CELL LYMPHOMA, GENE
• Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Multidrug resistance is a cause of treatment failure in patients with malignant lymphoma; however, the frequency and clinical relevance of multidrug resistance protein expression are unclear. The present study aimed to investigate expression of the most common multidrug resistance proteins in a group of lymphoma patients.